Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

2
Player Avatar DODEA (56.02) Submitted: 12/29/2008 11:53:02 AM : Outperform Start Price: $12.98 VIVO Score: +17.83

Meridian Biosciences has been a great pick for me since 1989. It was one of the very first stocks I owned, and my second DRIP. It has very strong financials, an intelligent business plan, and many products in its pipeline. This is an excellent small-cap stock for getting in on the ground floor.

Member Avatar pjgz (32.77) Submitted: 5/24/2010 11:20:02 PM
Recs: 0

Hey! DODEA,

I'm not aware of any pipeline upcoming blockbuster products right now, know of any?
I suspect that the BOD is milking this cash cow, since I see no acquisitions, and no new product development.
What is VIVO doing to secure it's future success. I'm afraid that if the don't invest soon that they will be left in the dust. Thoughts?

Featured Broker Partners


Advertisement